News & Events

New drug could help treat tough cancers, study finds

New drug could help treat tough cancers, study finds

Oncology expert reveals the impact of biomarker testing on the outcomes of targeted therapies for cancer

Oncology expert reveals the impact of biomarker testing on the outcomes of targeted therapies for cancer

Adagrasib Boosts Outcomes in KRAS G12C-Mutated Lung Cancer

Adagrasib Boosts Outcomes in KRAS G12C-Mutated Lung Cancer

The Targeted Pulse: Adagrasib Bests Docetaxel in Pretreated KRAS G12C-NSCLC, Adding Nivolumab to Tivozanib Yields No benefit in RCC, and More

The Targeted Pulse: Adagrasib Bests Docetaxel in Pretreated KRAS G12C-NSCLC, Adding Nivolumab to Tivozanib Yields No benefit in RCC, and More

NSCLC Biomarker Testing: Multidisciplinary Decisions and Timely Testing Are Key

NSCLC Biomarker Testing: Multidisciplinary Decisions and Timely Testing Are Key

Role of Pulmonologists in Precision Medicine: Attitudes Towards Biomarker Testing for NSCLC

Role of Pulmonologists in Precision Medicine: Attitudes Towards Biomarker Testing for NSCLC

Targeting KRAS Mutations in Cancer Therapy

Targeting KRAS Mutations in Cancer Therapy

How KRAS Inhibitors Are Transforming Cancer Therapy

How KRAS Inhibitors Are Transforming Cancer Therapy

Practice Updates in Lung Cancer Stem From Biomarker Testing and Up-Front Immunotherapy

Practice Updates in Lung Cancer Stem From Biomarker Testing and Up-Front Immunotherapy